0001127602-11-008732.txt : 20110303 0001127602-11-008732.hdr.sgml : 20110303 20110303160948 ACCESSION NUMBER: 0001127602-11-008732 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110301 FILED AS OF DATE: 20110303 DATE AS OF CHANGE: 20110303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOHAPATRA SURYA N CENTRAL INDEX KEY: 0001222671 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 11660337 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-03-01 0001022079 QUEST DIAGNOSTICS INC DGX 0001222671 MOHAPATRA SURYA N C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 1 Chairman, President & CEO Common Stock 2011-03-01 4 M 0 20555 48.74 A 388527 D Common Stock 2011-03-01 4 S 0 20555 56.7519 D 367972 D Common Stock 5166 I 401(k)/sdcp Stock Options (Right to Buy) 48.74 2011-03-01 4 M 0 20555 0 D 2012-02-22 Common Stock 20555 226111 D This transaction was executed in multiple trades at prices ranging from $56.62 to $56.9562. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. The options vested in three installments beginning with the first on February 22, 2006, the second on February 22, 2007 and the final on February 22, 2008. This exercise and sale reported were effected pursuant to Rule 10b-5-1 sales plan adopted by the reporting person on February 15, 2011. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Surya N. Mohapatra 2011-03-02